Champions Oncology Inc (CSBR)

4.010 +0.010 (+0.25%)
Closed USD Disclaimer

Champions Oncology Inc Company Profile

Equity Type
Champions Oncology, Inc. is a technology-enabled research organization engaged in creating transformative technology solutions to be utilized in drug discovery and development. The Company's research center operates in both regulatory and non-regulatory environments and consists of a set of computational and experimental research platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology companies. Its software as-a service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. Its drug discovery and development business leverages the computational and experimental capabilities within its platforms. Its discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify therapeutic targets.
Contact Information
Hackensack,07601 United States
201 808 8400
Top Executives
Ronnie Morris 55 2010 President, CEO & Director
Robert Brainin 50 2021 Independent Director
Scott R. Tobin 50 2011 Independent Director
Justin Stebbing 0 0000 Scientific Advisor
René Bernards 68 0000 Scientific Advisor
Harvey I. Pass 0 0000 Scientific Advisor
Philip P. Breitfeld 68 2016 Independent Director
David Sidransky 62 2007 Independent Lead Director
Manuel Hidalgo 54 2007 Scientific Advisor
Daniel N. Mendelson 57 2013 Independent Director
Misti Ushio 51 0000 Board Observer
Joel Ackerman 57 2010 Independent Chairman of the Board
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.